Giovanni Paganelli Selected Research

Avidin

10/2010	Therapeutic use of avidin is not hampered by antiavidin antibodies in humans.
2/2010	Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin.
9/2007	Intraoperative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer.
7/2006	Radioimmunotherapy of brain tumor.
10/2005	Preparation and characterization of active site protected poly(ethylene glycol)-avidin bioconjugates.
11/2003	Localization of avidin in superficial bladder cancer: a potentially new approach for radionuclide therapy.
5/2003	Characterization of poultry egg-white avidins and their potential as a tool in pretargeting cancer treatment.
9/2002	Poly(ethylene glycol)-avidin bioconjugates: suitable candidates for tumor pretargeting.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giovanni Paganelli Research Topics

Disease

56	Neoplasms (Cancer) 06/2022 - 04/2002
28	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 07/2013
26	Breast Neoplasms (Breast Cancer) 01/2022 - 02/2004
16	Neoplasm Metastasis (Metastasis) 01/2022 - 06/2002
15	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2021 - 04/2002
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 09/2007
5	Lymphoma (Lymphomas) 01/2022 - 11/2007
3	Glioma (Gliomas) 01/2021 - 02/2006
3	Lymphatic Metastasis 11/2011 - 10/2010
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 11/2003
2	Multiple Myeloma 01/2020 - 06/2012
2	Disease Progression 12/2018 - 09/2007
2	Carcinoid Tumor (Carcinoid) 06/2016 - 11/2010
2	Meningioma (Meningiomas) 01/2014 - 09/2009
2	Hematologic Neoplasms (Hematological Malignancy) 06/2012 - 03/2009
2	Nausea 02/2012 - 02/2003
2	Carcinoma (Carcinomatosis) 03/2008 - 04/2006
2	Brain Neoplasms (Brain Tumor) 07/2006 - 01/2006
2	Glioblastoma (Glioblastoma Multiforme) 04/2006 - 04/2005
1	Thrombosis (Thrombus) 01/2022
1	Venous Thromboembolism 01/2022
1	Thrombocytopenia (Thrombopenia) 08/2021
1	Leukopenia 08/2021
1	Tics (Tic) 01/2021
1	Xerostomia 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2019

Drug/Important Bio-Agent (IBA)

36	Radioisotopes (Radionuclides)IBA 01/2021 - 04/2002
18	Peptide Receptors (Peptide Receptor)IBA 01/2021 - 04/2002
10	AntigensIBA 02/2022 - 01/2013
10	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 08/2014 - 04/2002
8	Biotin (Vitamin H)FDA Link 04/2015 - 07/2003
8	AvidinIBA 10/2010 - 09/2002
7	Somatostatin Receptors (Somatostatin Receptor)IBA 12/2021 - 04/2002
6	Octreotide (Sandostatin)FDA LinkGeneric 11/2010 - 04/2002
5	LigandsIBA 01/2022 - 12/2017
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2019
4	Biological ProductsIBA 12/2021 - 09/2002
4	abirateroneIBA 01/2021 - 12/2014
4	enzalutamideIBA 01/2021 - 07/2015
4	AntibodiesIBA 02/2006 - 09/2002
4	Colloids (Colloid)IBA 06/2004 - 06/2002
3	gallium 68 PSMA-11IBA 11/2020 - 11/2018
3	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 10/2014 - 07/2003
3	Peptides (Polypeptides)IBA 08/2014 - 04/2002
3	ibritumomab tiuxetan (Zevalin)FDA Link 03/2014 - 07/2007
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2013 - 01/2007
3	Proteins (Proteins, Gene)FDA Link 08/2011 - 09/2002
3	Human Serum Albumin FDA LinkGeneric 01/2010 - 02/2004
3	DOTA-Tyr(3)- 90Y-octreotideIBA 03/2008 - 02/2004
2	Urea (Carbamide)FDA LinkGeneric 06/2022 - 12/2017
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2022 - 01/2022
2	177Lu-PSMA-617IBA 10/2021 - 12/2020
2	lutetium Lu 177 dotatateIBA 01/2021 - 03/2008
2	AlbuminsIBA 03/2020 - 01/2019
2	Indicators and Reagents (Reagents)IBA 01/2020 - 02/2004
2	Radium-223IBA 05/2019 - 01/2019
2	Messenger RNA (mRNA)IBA 09/2016 - 01/2008
2	Carcinoembryonic AntigenIBA 01/2013 - 02/2006
2	Amino Acids FDA Link 02/2012 - 02/2003
2	Monoclonal AntibodiesIBA 12/2011 - 04/2006
2	Glucose (Dextrose)FDA LinkGeneric 08/2011 - 07/2008
2	Yttrium-90IBA 04/2009 - 07/2007
2	TenascinIBA 04/2006 - 10/2005
2	Coloring Agents (Dyes)IBA 03/2004 - 06/2002
1	PSMA I&TIBA 06/2022
1	HydrogelsIBA 02/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	pertuzumabIBA 01/2022
1	Lutetium-177IBA 10/2021
1	Androgen Receptors (Androgen Receptor)IBA 10/2021
1	cabazitaxel FDA Link 08/2021
1	RadiopharmaceuticalsIBA 06/2021
1	AndrogensIBA 01/2021
1	177Lu-DOTA-octreotateIBA 01/2021
1	Capecitabine (Xeloda)FDA Link 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	APTIBA 01/2021
1	alovudineIBA 01/2021
1	thiamine triphosphorate (TTP)IBA 01/2021
1	Polyglutamic Acid (Polyglutamate)IBA 12/2020
1	PSMA-617IBA 12/2020
1	Chimeric Antigen ReceptorsIBA 10/2019
1	Choline (Choline Chloride)IBA 12/2018

Therapy/Procedure

56	Therapeutics 01/2022 - 04/2002
16	Castration 01/2022 - 12/2014
12	Radioimmunotherapy 01/2022 - 06/2004
10	Radiotherapy 01/2021 - 09/2007
7	Drug Therapy (Chemotherapy) 01/2022 - 04/2005
5	Neoadjuvant Therapy 01/2021 - 06/2007
4	Lymph Node Excision (Lymph Node Dissection) 12/2006 - 06/2002
3	Precision Medicine 06/2022 - 12/2017
2	Immunotherapy 01/2021 - 04/2005
2	Aftercare (After-Treatment) 07/2008 - 11/2007
2	Local Anesthesia 10/2007 - 01/2005
2	Stem Cell Transplantation 09/2007 - 07/2007
1	Microspheres (Microsphere) 02/2022
1	Injections 02/2022
1	Retreatment 11/2020
1	Salvage Therapy 01/2020